Proto Labs Inc: Form 10-Q for the period ended Jun 30, 2016
Filed with the SEC on Aug 4, 2016 and accepted by EDGAR at Aug 4, 2016, 10:52 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-04-01 to 2016-06-30 | $75.0m | us-gaap:SalesRevenueNet |
| Revenue | 6 months2016-01-01 to 2016-06-30 | $147.5m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2016-04-01 to 2016-06-30 | $32.7m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2016-01-01 to 2016-06-30 | $65.6m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2016-04-01 to 2016-06-30 | $42.2m | us-gaap:GrossProfit |
| Gross profit | 6 months2016-01-01 to 2016-06-30 | $81.9m | us-gaap:GrossProfit |
| Research and development | 3 months2016-04-01 to 2016-06-30 | $5.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2016-01-01 to 2016-06-30 | $11.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2016-04-01 to 2016-06-30 | $14.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2016-01-01 to 2016-06-30 | $30.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2016-04-01 to 2016-06-30 | $5.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2016-01-01 to 2016-06-30 | $10.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-04-01 to 2016-06-30 | $10.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2016-01-01 to 2016-06-30 | $21.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-04-01 to 2016-06-30 | $0.40 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2016-01-01 to 2016-06-30 | $0.80 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-04-01 to 2016-06-30 | $0.41 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2016-01-01 to 2016-06-30 | $0.81 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-04-01 to 2016-06-30 | 26,561,148 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2016-01-01 to 2016-06-30 | 26,526,629 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2016-01-01 to 2016-06-30 | $36.6m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months2016-01-01 to 2016-06-30 | $22.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2016-06-30 | $57.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-06-30 | $148.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-06-30 | $388.0m | us-gaap:Assets |
| Current liabilities | At period end2016-06-30 | $23.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-06-30 | $31.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2016-06-30 | $356.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-16-036401. Last ingested by Listed: Nov 4, 2026, 18:20 ET. Listed shows no prices and gives no investment advice.